
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-05-13 | Gerald E. Connolly | house | Sale | $1,001 - $15,000 |
| 2025-02-05 | Gerald E. Connolly | house | Sale | $1,001 - $15,000 |
| 2024-10-10 | Gerald E. Connolly | house | Sale | $1,001 - $15,000 |
| 2024-07-02 | Gerald E. Connolly | house | Sale | $1,001 - $15,000 |
| 2024-03-18 | Gerald E. Connolly | house | Sale | $1,001 - $15,000 |
| Metric | FY2026 | FY2025 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenues | $17.17B+3.1% | $16.66B+7.9% | $15.44B+7.2% | $14.40B+4.8% | $13.74B |
| Cost of revenues | $14.07B+1.5% | $13.86B+5.1% | $13.19B+7.2% | $12.31B+5.0% | $11.72B |
| Selling, general and administrative expenses | $999.0M+1.6% | $983.0M+4.4% | $942.0M-0.9% | $951.0M+11.8% | $851.0M |
| Acquisition, integration and restructuring costs | $18.0M+12.5% | $16.0M-33.3% | $24.0M+41.2% | $17.0M-37.0% | $27.0M |
| Goodwill impairment charges | $0 | $0-100.0% | $596.0M | $0 | $0 |
| Asset impairment charges | $5.0M-54.5% | $11.0M-87.9% | $91.0M+127.5% | $40.0M+900.0% | $4.0M |
| Equity earnings of non-consolidated subsidiaries | -$32.0M+17.9% | -$39.0M-30.0% | -$30.0M-150.0% | -$12.0M+40.0% | -$20.0M |
| Operating income | $2.11B+15.4% | $1.83B+194.2% | $621.0M-42.9% | $1.09B-5.6% | $1.15B |
| Interest expense, net | -$203.0M-5.2% | -$193.0M+9.0% | -$212.0M-6.5% | -$199.0M-8.2% | -$184.0M |
| Other income (expense), net | $3.0M-40.0% | $5.0M+183.3% | -$6.0M-100.0% | -$3.0M | — |
| Income before income taxes | $1.91B+16.5% | $1.64B+306.7% | $403.0M-54.5% | $886.0M-8.4% | $967.0M |
| Income tax expense | -$447.0M-15.2% | -$388.0M-99.0% | -$195.0M-1.0% | -$193.0M+7.2% | -$208.0M |
| Net income | $1.46B+16.9% | $1.25B+501.4% | $208.0M-70.0% | $693.0M-8.7% | $759.0M |
| Less: net income (loss) attributable to non-controlling interest | $14.0M+566.7% | -$3.0M-133.3% | $9.0M | — | — |
| Net income attributable to Leidos common stockholders | $1.45B+15.5% | $1.25B+530.2% | $199.0M-70.9% | $685.0M-9.0% | $753.0M |
| Basic (in dollars per share) | $11.3M+20.8% | $9.4M+545.5% | $1.4M-71.0% | $5.0M | — |
| Diluted (in dollars per share) | $11.1M+20.8% | $9.2M+540.3% | $1.4M-71.0% | $5.0M | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
BigBear.ai Before Q1 Earnings: Buy, Sell or Hold the Stock?
U.S. seeks to deploy hypersonic missile for possible use against Iran - report
Leidos (LDOS) Exceeds Market Returns: Some Facts to Consider
Leidos Wins US$456m Contract As Health Services Role And Valuation Stand Out